157 related articles for article (PubMed ID: 21048261)
1. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit.
Murki S; Jonnala S; Mohammed F; Reddy A
Indian Pediatr; 2010 Sep; 47(9):785-8. PubMed ID: 21048261
[TBL] [Abstract][Full Text] [Related]
2. Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit.
Sehgal R; Gaind R; Chellani H; Agarwal P
Ann Trop Paediatr; 2007 Mar; 27(1):45-54. PubMed ID: 17469732
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital.
Jain A; Roy I; Gupta MK; Kumar M; Agarwal SK
J Med Microbiol; 2003 May; 52(Pt 5):421-425. PubMed ID: 12721319
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.
Rameshkumar G; Ramakrishnan R; Shivkumar C; Meenakshi R; Anitha V; Venugopal Reddy YC; Maneksha V
Indian J Ophthalmol; 2016 Apr; 64(4):303-11. PubMed ID: 27221683
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital.
Bhattacharjee A; Sen MR; Prakash P; Gaur A; Anupurba S
Indian J Med Microbiol; 2008; 26(4):356-60. PubMed ID: 18974490
[TBL] [Abstract][Full Text] [Related]
6. Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.
Ndugulile F; Jureen R; Harthug S; Urassa W; Langeland N
BMC Infect Dis; 2005 Oct; 5():86. PubMed ID: 16225701
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.
Tsai MH; Lee IT; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
PLoS One; 2016; 11(8):e0159744. PubMed ID: 27505270
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
Huang Y; Zhuang S; Du M
Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
[TBL] [Abstract][Full Text] [Related]
9. [Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?].
Kola A; Gastmeier P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):573-6. PubMed ID: 12975735
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for infection and/or colonisation with extended-spectrum β-lactamase-producing bacteria in the neonatal intensive care unit: a meta-analysis.
Li X; Xu X; Yang X; Luo M; Liu P; Su K; Qing Y; Chen S; Qiu J; Li Y
Int J Antimicrob Agents; 2017 Nov; 50(5):622-628. PubMed ID: 28733213
[TBL] [Abstract][Full Text] [Related]
11. Bacteriological profile and clinical predictors of ESBL neonatal sepsis.
Sharma D; Kumar C; Pandita A; Pratap OT; Dasi T; Murki S
J Matern Fetal Neonatal Med; 2016; 29(4):567-70. PubMed ID: 25666741
[TBL] [Abstract][Full Text] [Related]
12. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
14. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
Vinodkumar CS; Neelagund YF
Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
[TBL] [Abstract][Full Text] [Related]
15. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010.
Badal RE; Bouchillon SK; Lob SH; Hackel MA; Hawser SP; Hoban DJ
Pediatr Infect Dis J; 2013 Jun; 32(6):636-40. PubMed ID: 23838732
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
Kader AA; Kumar AK
Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
Sharma R; Park TE; Moy S
Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
[TBL] [Abstract][Full Text] [Related]
19. β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
Gutkind GO; Di Conza J; Power P; Radice M
Curr Pharm Des; 2013; 19(2):164-208. PubMed ID: 22894615
[TBL] [Abstract][Full Text] [Related]
20. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
Zaki Mel S
J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
